MedPath

Postoperative Rehabilitation in Operation for LUng CAncer (PROLUCA)

Not Applicable
Conditions
Lung Cancer
Interventions
Behavioral: Rehabilitation
Registration Number
NCT02439073
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

Purpose The purpose of the PROLUCA study is to investigate the efficacy of early postoperative rehabilitation in a non-hospital setting in patients with operable lung cancer, with focus on exercise training.

Design/Methods

One hundred and twenty-eight (n=128) participants (64 patients/study arm) with Non-Small Cell Lung Cancer (NSCLC), stage I-IIIa, referred for surgery, will be randomized to one of the following two groups:

1. Early postoperative rehabilitation initiated as early as two weeks after surgery

2. Postoperative rehabilitation initiated 14 weeks after surgery Intervention The intervention consists of a supervised group exercise program comprising resistance and cardiorespiratory exercise two hours weekly for 12 weeks combined with individual counseling.

The primary study endpoint is Maximal oxygen uptake measured by a VO2peak test (direct measurement) Secondary endpoints include: Six minutes walk distance (6MWD), One-repetition-maximum (1RM) Patient-reported outcomes (PROs) on health related quality of life, fatigue, depression, lifestyle, postoperative complications, hospitalization time, sick leave, work status and survival.

Results The results of PROLUCA will identify the optimal timing of postoperative rehabilitation in NSCLC patients with focus on increasing physical capacity and health related quality of life and reducing the side effects from the treatment of the cancer disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
235
Inclusion Criteria
  • All subjects are assigned for curative lung cancer surgery at Department of Cardiothoracic Surgery RT at Copenhagen University Hospital (Rigshospitalet)
  • Performance status 0-2 (WHO)
  • Living in the City of Copenhagen or surrounding Municipalities
  • Ability to read and understand Danish
  • Approval by primary surgeon
Exclusion Criteria
  • Presence of metastatic disease or surgical inoperability. Diagnosis of Lung Cancer not verified by histological diagnosis.
  • Decompensated heart failure, severe aortic stenosis, uncontrolled arrhythmia, acute coronary syndrome
  • Contraindications to maximal exercise testing as recommended by the American Thoracic Society and exercise testing guidelines for cancer patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
early initiated rehabilitationRehabilitationA supervised 12-week rehabilitation program, initiated two weeks post surgery, containing 24 group-based exercise sessions, three individual counseling sessions, and three group-based lessons in health-promoting behavior. If the participants have special needs in terms of smoking cessation, nutritional counseling or patient education, this is offered too.
late initiated rehabilitationRehabilitationA supervised 12-week rehabilitation program, initiated 14 weeks post surgery, containing 24 group-based exercise sessions, three individual counseling sessions, and three group-based lessons in health-promoting behavior. If the participants have special needs in terms of smoking cessation, nutritional counseling or patient education, this is offered too.
Primary Outcome Measures
NameTimeMethod
A change in maximum oxygen consumptionA change in maximum oxygen consumption from baseline to post intervention (for group one, the experimental group, it is approximately 14 weeks after the operation and for group two it is approximately 26 weeks after the operation)

A change in maximum oxygen consumption from baseline to post interventon, measured by a VO2peak, evaluated by an incremental test using an electromagnetically braked cycle ergometer

Secondary Outcome Measures
NameTimeMethod
Patient Reported outcomesBaseline, post intervention, follow-up at 26 and 52 weeks after surgery

EORTC QLQ-C30, EORTC-LC13, FACT-L, SF-36, HADS, The distress thermometer, MSPSS, PAS2

Lung capacityBaseline, two and 8 weeks after surgery. post intervention, follow-up at 26 and 52 weeks after surgery

Spirometry

Muscle strength chest and leg pressBaseline, post intervention, follow-up at 26 and 52 weeks after surgery

one repetition maximum

Six minutes walk distanceBaseline, two and 8 weeks after surgery. post intervention, follow-up at 26 and 52 weeks after surgery
A change in maximum oxygen consumptionA change in maximum oxygen consumption from baseline to 52 weeks after operation

measured by a VO2peak, evaluated by an incremental test using an electromagnetically braked cycle ergometer

Trial Locations

Locations (1)

Copenhagen Centre for Cancer and Health

🇩🇰

Copenhagen, Capital region of Denmark, Denmark

© Copyright 2025. All Rights Reserved by MedPath